Inhibrx Biosciences, Inc.
INBX • NASDAQ • Stock Fundamentals
Inhibrx Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mark Paul Lappe, with a market cap of $1.6B.
Market Cap$1.6B
Employees172.0
CEOMark Paul Lappe
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Inhibrx Biosciences, Inc. FAQ
Common questions about Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. (INBX) has a market capitalization of $1.6B and trades on NASDAQ.
Inhibrx Biosciences, Inc. has approximately 172 employees.